Labor market exit around retirement age in Sweden and trajectories of psychotropic drugs in a context of downsizing.
Anti-Anxiety Agents
/ therapeutic use
Antidepressive Agents
/ therapeutic use
Central Nervous System Depressants
/ administration & dosage
Disabled Persons
Employment
/ psychology
Female
Humans
Hypnotics and Sedatives
/ therapeutic use
Longitudinal Studies
Male
Mental Health
Middle Aged
Occupations
Organizational Innovation
Pensions
/ statistics & numerical data
Prospective Studies
Retirement
/ psychology
Sweden
Unemployment
/ psychology
Workplace
Disability pension
Downsizing
Longitudinal analysis
Psychotropic drugs
Retirement
Sick-leave
Unemployment
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
05 May 2020
05 May 2020
Historique:
received:
22
03
2019
accepted:
25
03
2020
entrez:
7
5
2020
pubmed:
7
5
2020
medline:
24
9
2020
Statut:
epublish
Résumé
A maintained psychological wellbeing is important in order to continue working longer and remain active into older age. However, little is known about impact of different organizational factors, such as downsizing, on the mental health of older workers exiting the labor market. The aim in this study was to investigate trajectories of purchases of psychotropic drugs in relation to labor market exit later in life in a context with and without downsizing. People living in Sweden, born 1941-1951, exiting paid work via unemployment, sickness absence/disability pension, or old-age pension were followed from 2005 to 2013 regarding purchases of psychotropic drugs. Individuals employed at a workplace closing down or downsizing with ≥18% between two subsequent years were compared to employees exiting from workplaces without downsizing or workplace closure. Generalized estimating equations was applied to derive trajectories of annual prevalence of purchased antidepressants, sedatives and anxiolytics from 4 years before to 4 years after a labour market exit. During the period around the exit, old-age retirees experiencing a downsizing/workplace closure did not decrease their purchases of sedatives (OR 1.01 95% CI 0.95-1.07) while the unexposed decreased their purchases during this period (OR 0.95 95% CI 0.92-0.98). Similar differences concerning sedatives and antidepressants between exposed and unexposed were seen for those exiting via sickness absence or disability pension. Furthermore, a significant difference in purchases of anxiolytics was observed between those exposed to downsizing (OR 1.10 95% CI 0.97-1.24) and the unexposed (OR 0.98 95% CI 0.91-1.06) exiting via old-age retirement during the time before the exit. Downsizing or workplace closure, although weakly, was associated with higher prevalence of psychotropic drugs certain years around the labor market exit. The results support the idea that involuntary labor market exit in mature adulthood may negatively affect the development of mental health.
Sections du résumé
BACKGROUND
BACKGROUND
A maintained psychological wellbeing is important in order to continue working longer and remain active into older age. However, little is known about impact of different organizational factors, such as downsizing, on the mental health of older workers exiting the labor market. The aim in this study was to investigate trajectories of purchases of psychotropic drugs in relation to labor market exit later in life in a context with and without downsizing.
METHOD
METHODS
People living in Sweden, born 1941-1951, exiting paid work via unemployment, sickness absence/disability pension, or old-age pension were followed from 2005 to 2013 regarding purchases of psychotropic drugs. Individuals employed at a workplace closing down or downsizing with ≥18% between two subsequent years were compared to employees exiting from workplaces without downsizing or workplace closure. Generalized estimating equations was applied to derive trajectories of annual prevalence of purchased antidepressants, sedatives and anxiolytics from 4 years before to 4 years after a labour market exit.
RESULTS
RESULTS
During the period around the exit, old-age retirees experiencing a downsizing/workplace closure did not decrease their purchases of sedatives (OR 1.01 95% CI 0.95-1.07) while the unexposed decreased their purchases during this period (OR 0.95 95% CI 0.92-0.98). Similar differences concerning sedatives and antidepressants between exposed and unexposed were seen for those exiting via sickness absence or disability pension. Furthermore, a significant difference in purchases of anxiolytics was observed between those exposed to downsizing (OR 1.10 95% CI 0.97-1.24) and the unexposed (OR 0.98 95% CI 0.91-1.06) exiting via old-age retirement during the time before the exit.
CONCLUSION
CONCLUSIONS
Downsizing or workplace closure, although weakly, was associated with higher prevalence of psychotropic drugs certain years around the labor market exit. The results support the idea that involuntary labor market exit in mature adulthood may negatively affect the development of mental health.
Identifiants
pubmed: 32370787
doi: 10.1186/s12889-020-08589-6
pii: 10.1186/s12889-020-08589-6
pmc: PMC7201680
doi:
Substances chimiques
Anti-Anxiety Agents
0
Antidepressive Agents
0
Central Nervous System Depressants
0
Hypnotics and Sedatives
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
618Subventions
Organisme : Forskningsrådet om Hälsa, Arbetsliv och Välfärd
ID : 2009-1758
Organisme : Forskningsrådet om Hälsa, Arbetsliv och Välfärd
ID : 2012-1743
Organisme : Forskningsrådet för Arbetsliv och Socialvetenskap
ID : 2007-1762
Références
Ind Health. 2011;49(3):353-64
pubmed: 21372437
Biometrics. 2001 Mar;57(1):120-5
pubmed: 11252586
Epidemiology. 2016 Mar;27(2):257-64
pubmed: 26501153
J Ment Health Policy Econ. 2016 Mar;19(1):33-44
pubmed: 27084792
J Appl Psychol. 2005 Jan;90(1):53-76
pubmed: 15641890
Annu Rev Psychol. 1998;49:377-412
pubmed: 9496627
Lancet. 1997 Oct 18;350(9085):1124-8
pubmed: 9343499
J Occup Environ Med. 2010 Jun;52(6):576-83
pubmed: 20523241
BMC Public Health. 2015 Aug 01;15:738
pubmed: 26232123
J Affect Disord. 2003 Sep;76(1-3):255-9
pubmed: 12943956
J Affect Disord. 2011 Dec;135(1-3):10-9
pubmed: 21300408
Scand J Work Environ Health. 2012 Sep;38(5):409-17
pubmed: 22411588
Sleep. 2018 Jan 1;41(1):
pubmed: 29155955
Occup Environ Med. 2005 Feb;62(2):135-40
pubmed: 15657199
Aging Ment Health. 2015;19(5):381-9
pubmed: 24946236
Eur J Epidemiol. 2013 May;28(5):417-26
pubmed: 23508328
J Epidemiol Community Health. 2013 Sep;67(9):796-802
pubmed: 23814273
Occup Environ Med. 2015 May;72(5):366-72
pubmed: 25814269
BMJ. 2012 May 09;344:e2316
pubmed: 22573646
Occup Environ Med. 2017 Mar;74(4):301-310
pubmed: 28108676
BMC Public Health. 2017 Feb 8;17(1):176
pubmed: 28178966
Soc Sci Med. 2012 Sep;75(5):946-53
pubmed: 22682662
Epidemiology. 2011 Jul;22(4):553-9
pubmed: 21502864
Am J Community Psychol. 2003 Sep;32(1-2):57-67
pubmed: 14570435
Scand J Work Environ Health. 2017 Jul 1;43(4):307-315
pubmed: 28350411
Lancet. 2015 Feb 14;385(9968):640-648
pubmed: 25468152
Soc Sci Med. 1987;25(2):153-61
pubmed: 3660005
Clin Epidemiol. 2015 Nov 23;7:491-508
pubmed: 26648756
Occup Environ Med. 2012 Aug;69(8):592-8
pubmed: 22544854
J Epidemiol Community Health. 2007 Feb;61(2):154-8
pubmed: 17234876
Eur J Ageing. 2012 Nov 7;10(1):25-35
pubmed: 28804280
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
pubmed: 16897791
BMC Public Health. 2013 Dec 13;13:1180
pubmed: 24330730
Scand J Work Environ Health. 2013 Mar 1;39(2):125-33
pubmed: 22949091